Microsoft, Meta, Comcast and Biogen rise premarket; Qualcomm falls

Investing.com -- U.S. stock futures rose sharply Thursday, with investors digesting earnings from a couple of tech giants, the Federal Reserve policy decision and more labor market data.

Here are some of the biggest premarket U.S. stock movers today:

• Microsoft (NASDAQ:MSFT) stock rose 8.2% after the software giant reported an impressive performance from its important cloud computing division, known as Azure, as fiscal fourth-quarter revenue jumped by 39%.

• Meta Platforms (NASDAQ:META) stock soared over 11% after strength in the Facebook-owner’s crucial advertising business powered better-than-anticipated sales in the April-to-June period.

• Nvidia (NASDAQ:NVDA) stock rose 2.2% despite China raising concerns over potential security risks in the chipmaker’s H20 artificial intelligence chip, casting uncertainty over the U.S. company’s sales prospects.

• Comcast (NASDAQ:CMCSA) stock rose 3.8% after the mass media giant reported stronger-than-expected second-quarter results despite a loss of broadband customers.

• Biogen (NASDAQ:BIIB) stock rose 4.3% after the drugmaker posted better-than-anticipated first-quarter revenue and raised its full-year guidance thanks in part to solid sales of its Alzheimer’s drug.

• Qualcomm (NASDAQ:QCOM) stock fell 7.1% as the looming loss of Apple (NASDAQ:AAPL) as the chip maker’s biggest modem customer outweighed its upbeat quarterly forecast.

• Norwegian Cruise Line (NYSE:NCLH) stock rose 6.6% after the cruise operator reported record second-quarter revenue and reaffirmed full-year guidance.

• Ford (NYSE:F) stock fell 0.6% after the auto giant lowered its full-year earnings outlook due to a $2 billion net headwind from tariffs.

• CVS Health (NYSE:CVS) stock surged 7.6% after the health insurer raised its annual profit forecast after beating estimates for second-quarter profit, as tight oversight of higher medical costs led to improved performance for its Aetna health insurance business.

• KKR (F:KR51) stock rose 0.4% after the investment giant reported a 9% rise in adjusted net income for the second quarter, bolstered by an increase in fee-related earnings.

• Arm Holdings (NASDAQ:ARM) ADRs fell 6.5% after the chip tech provider’s plan to invest in its own chip development, which would bite into future profits, disappointed investors.

• Argenx (NASDAQ:ARGX) ADRs soared 15% after the biotech posted $949 million in global product net sales for the second quarter, marking a 97% surge year-over-year and 19% sequentially.

• HF Sinclair (NYSE:DINO) stock rose 2.5% after the refiner beat Wall Street estimates for second-quarter profit, helped by higher refining margins.

• Alignment Healthcare (NASDAQ:ALHC) stock surged 21% after the health-care company posted better-than-expected second-quarter results as well as solid guidance.